InnoCan Pharma Corporation
INNO
Ранг среди акций
#33927
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Цена акции
$1.35
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$6.08M
Изменение (1 день)
-3.08%
Изменение (1 год)
-89.20%
Страна
CA
Торговля InnoCan Pharma Corporation (INNO)
Категория
Healthcare
История цены акций InnoCan Pharma Corporation (INNO)
Наивысшая цена закрытия: $1.37 2026-10-01
Наименьшая цена закрытия: $11.93 2020-11-01
Наименьшая цена закрытия: $11.93 2020-11-01
История цены акций InnoCan Pharma Corporation с 2020 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | -38.79% |
| 2025 | -29.02% |
| 2024 | -47.91% |
| 2023 | 42.26% |
| 2022 | -67.12% |
| 2021 | 201.26% |
| 2020 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.16 | 21.27% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $222.14 | 29.72% |
CH
|
|
| $18.46 | -3.87% |
IN
|
